AU2001261005A1 - Immune mediators and related methods - Google Patents

Immune mediators and related methods

Info

Publication number
AU2001261005A1
AU2001261005A1 AU2001261005A AU6100501A AU2001261005A1 AU 2001261005 A1 AU2001261005 A1 AU 2001261005A1 AU 2001261005 A AU2001261005 A AU 2001261005A AU 6100501 A AU6100501 A AU 6100501A AU 2001261005 A1 AU2001261005 A1 AU 2001261005A1
Authority
AU
Australia
Prior art keywords
related methods
immune mediators
mediators
immune
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261005A
Inventor
Subhashini Arimilli
Darrick Carter
Aijun Wang
Shirley Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001261005A1 publication Critical patent/AU2001261005A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/605—MHC molecules or ligands thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
AU2001261005A 2000-03-22 2001-03-22 Immune mediators and related methods Abandoned AU2001261005A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US19127400P 2000-03-22 2000-03-22
US60/191,274 2000-03-22
US20424900P 2000-05-15 2000-05-15
US60/204,249 2000-05-15
US26400301P 2001-01-23 2001-01-23
US60/264,003 2001-01-23
PCT/US2001/009616 WO2001070245A1 (en) 2000-03-22 2001-03-22 Immune mediators and related methods

Publications (1)

Publication Number Publication Date
AU2001261005A1 true AU2001261005A1 (en) 2001-10-03

Family

ID=27392878

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261005A Abandoned AU2001261005A1 (en) 2000-03-22 2001-03-22 Immune mediators and related methods

Country Status (4)

Country Link
EP (1) EP1307211A4 (en)
AU (1) AU2001261005A1 (en)
CA (1) CA2403432A1 (en)
WO (1) WO2001070245A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001094418A2 (en) * 2000-06-05 2001-12-13 Corixa Corporation Leader peptides for enhancing secretion of recombinant protein from a host cell
EP1749889A1 (en) * 2000-06-05 2007-02-07 Corixa Corporation Leader peptides for enhancing secretion of recombinant protein from a host cell
NZ533587A (en) * 2001-11-16 2005-11-25 Pharmexa As Immunogenic mimetics of multimer proteins with promiscuous T cell epitope inserts
US8314210B2 (en) 2002-07-12 2012-11-20 Dana-Farber Cancer Institute, Inc. Compositions and methods for the generation of MHC class II compounds by peptide exchange
US20050287631A1 (en) * 2003-11-25 2005-12-29 Martin Kroenke Compositions and methods related to a dimeric MHC class I and II-Like molecule (dsMHCI and dsMHCII)
US7576183B2 (en) * 2003-12-24 2009-08-18 Los Alamos National Security, Llc Structure-based receptor MIMICS targeted against bacterial superantigen toxins
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP2167537A2 (en) 2007-07-03 2010-03-31 Dako Denmark A/S Compiled methods for analysing and sorting samples
EP2197908A2 (en) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194425A (en) * 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
US6015884A (en) * 1996-03-28 2000-01-18 The Johns Hopkins University Soluble divalent and multivalent heterodimeric analogs of proteins
US6268411B1 (en) * 1997-09-11 2001-07-31 The Johns Hopkins University Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
WO1999009064A1 (en) * 1997-08-19 1999-02-25 Mount Sinai School Of Medicine Of New York University ; Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules
WO1999014236A1 (en) * 1997-09-16 1999-03-25 Oregon Health Sciences University Recombinant mhc molecules useful for manipulation of antigen-specific t-cells

Also Published As

Publication number Publication date
EP1307211A4 (en) 2005-01-05
WO2001070245A1 (en) 2001-09-27
EP1307211A1 (en) 2003-05-07
CA2403432A1 (en) 2001-09-27
WO2001070245A9 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2001275441A1 (en) Filter arrangement and methods
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001241614A1 (en) Fluid-activatable adhesive articles and methods
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2001253418A1 (en) Compounds and methods
AU2002220473A1 (en) Toughened plastics and its preparation method
AU2002211717A1 (en) Stresscopins and their uses
AU2001261005A1 (en) Immune mediators and related methods
AU2001236716A1 (en) Antigenic complexes and methods
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU1083501A (en) Antibiotic-metal complex and methods
AU2001265026A1 (en) Oilseed extract products and uses
AU2001266176A1 (en) Methods
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU2001253481A1 (en) Methods and compositions for eleciting an immune response
AU2001210572A1 (en) Ornament
AU2002256556A1 (en) Sea-trosy and related methods
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2001250536A1 (en) Methods
AU2001261534A1 (en) The meca-79 antigen and related methods
AU2002235277A1 (en) Compounds and methods